Prothena
PRTA
#7625
Rank
โ‚น44.24 B
Marketcap
โ‚น845.08
Share price
0.92%
Change (1 day)
55.60%
Change (1 year)

Revenue for Prothena (PRTA)

Revenue in 2026 (TTM): โ‚น5.37 Billion

According to Prothena's latest financial reports the company's current revenue (TTM ) is โ‚น5.59 Billion. In 2025 the company made a revenue of โ‚น0.86 Billion a decrease over the revenue in the year 2024 that were of โ‚น11.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prothena from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น5.37 B517.82%
2025 โ‚น0.86 B-92.5%
2024 โ‚น11.59 B52.43%
2023 โ‚น7.60 B70.52%
2022 โ‚น4.46 B-70.12%
2021 โ‚น14.92 B23831.38%
2020 โ‚น62.38 M7.47%
2019 โ‚น58.04 M-13.07%
2018 โ‚น66.77 M-96.2%
2017 โ‚น1.75 B2350.9%
2016 โ‚น71.69 M-32.87%
2015 โ‚น0.10 B-96.69%
2014 โ‚น3.22 B7617.37%
2013 โ‚น41.76 M-71.3%
2012 โ‚น0.14 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amarin Corporation
AMRN
โ‚น20.93 B 274.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
โ‚น414.03 B 7,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น150.88 B 2,596.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland